HYLA Targets 300% Growth Rate Per Year
See Video at: https://youtu.be/6D2vlhy-jWU
Since acquiring HYLA,
Highlights include:
- Sales of HYLA products exceeded five million in the first 14 months since product launch.
- Distribution into 11 international countries with opening orders in 2023.
- Secured Government approvals to sell Hyla products in each country.
Secured Key Distribution Partners in theUAE andItaly targeting regions in theMiddle East andEurope .- Re-Order rates are accelerating as product adoption and demand exceeds expectations.
- Product placement in over 5000 international locations in first 8 countries.
- Uplisted Stock to OTCQB: Venture Market in
July 2023 - Consolidated HYLA Financials and completed PCAOB audit of the combined Enterprise in Q4
- Endexx Products in over 11,000 stores internationally and domestically combined.
Endexx restructured convertible debt to fixed debt to enable the company to benefit from a high rate of growth- Reduced operating costs driving company to gross profitability.
“Endexx has dramatically expanded its revenues on plant-based consumer products and its international footprint over the past year. Pivoting in 2022 to acquire HYLA was a key factor in our success in 2023,” stated
“While the past year has been challenging, we really are seeing incredible traction for Hyla products both domestically and abroad,” says Hyla CEO
www.endexx.com & www.cbdunlimited.com
www.tryhyla.com
About
Hyla currently markets its proprietary non-nicotine, guarana and L-Dopa-based vape products in a wide variety of flavors. The Hyla device is the first non-nicotine vape product to be produced in this manner in
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
We caution that any forward-looking statements (as such term is defined in the
Except as may be required by law, we assume no obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events, even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized. More information on potential factors that could affect our results is included “Risk Factors” in our amended Annual Report on Form 10-K/A filed with the
No Offer or Solicitation. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and, where applicable, the requirements under the securities laws of any other applicable jurisdiction.
For further information, please contact:
IR@Endexx.com
https://endexx.com/investors/
480-595-6900
Source:
2023 GlobeNewswire, Inc., source